| TRANSMEDICS GROUP |
| USA |
| Gesundheit |
| US89377M1099 / A2PH5P |
| 8T8 (Frankfurt) / TMDX (NASDAQ) |
| FRA:8T8, ETR:8T8, 8T8:GR, NASDAQ:TMDX |
| - |
| https://www.transmedics.c.. |
|
TransMedics Group Inc. is a medical technology company focused on the commercialization of organ transplant therapy systems. The company has developed the Organ Care System (OCS), a transformative and..
>Volltext.. |
| 3908.37 Mio. EUR |
| 3953.72 Mio. EUR |
| 481.04 Mio. EUR |
| 103.07 Mio. EUR |
| 77.94 Mio. EUR |
| 2.3 EUR |
| 441.11 Mio. EUR |
| 395.95 Mio. EUR |
| 151.18 Mio. EUR |
| 5.85 |
| 33.98% |
| 166.78% |
| - |
| - |
| - |
| - |
| TRANSMEDICS |
| 25.02.26 |
|
||||
|
||||
|